Market Cap 8.18B
Revenue (ttm) 113.29M
Net Income (ttm) -351.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.18%
Debt to Equity Ratio 0.00
Volume 12,468,700
Avg Vol 8,911,958
Day's Range N/A - N/A
Shares Out 1.06B
Stochastic %K 37%
Beta 0.04
Analysts Strong Sell
Price Target $11.94

Company Profile

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 696 5235
Address:
3530 John Hopkins Court, San Diego, United States
BixbyKnolls
BixbyKnolls Sep. 12 at 10:34 PM
$IBRX whats thr next step? https://lymphocytecount.org/
0 · Reply
todn
todn Sep. 12 at 10:31 PM
$IBRX — this is what a squeeze building sooner rather than later looks like. Bears threw everything at it, including the kitchen sink: ~72% short volume on Thursday. Next session the stock ripped back with a vengeance on much higher volume and closed green. That’s not strength for the shorts. That’s absorption. They emptied the clip and still couldn’t keep it red. This is how the setup looks before it goes
0 · Reply
itco803
itco803 Sep. 12 at 10:23 PM
$IBRX https://x.com/DrPatrick/status/2098771147211038843
0 · Reply
MrMulally
MrMulally Sep. 12 at 10:09 PM
$IBRX Not sure this has been posted here but this poster on X has over 155k followers, has made a few great calls in the past like AMD and PLTR etc…. He is a big fan of our good Dr. Pat . FWIW
0 · Reply
Outcomes
Outcomes Sep. 12 at 10:04 PM
$IBRX ….fight! 🦾 https://x.com/drpatrick/status/2098892737848430711?s=46
0 · Reply
mnholdem
mnholdem Sep. 12 at 8:19 PM
$IBRX “CAR-T cell therapy is a powerful cancer treatment, but its effectiveness and broad use are limited by severe side effects, difficulties treating solid tumors, and high costs.” Severe ToxicitiesCytokine Release Syndrome (CRS): A dangerous, systemic inflammatory response causing high fevers and dangerously low blood pressure.Neurotoxicity (ICANS): Immune effector cell-associated neurotoxicity syndrome causes confusion, seizures, and other cognitive difficulties. Many biotechs have a piece of the puzzle. Dr. Soon-Shiong‘s platforms have a much more wholistic approach with an excellent safety profiles.
0 · Reply
mnholdem
mnholdem Sep. 12 at 8:10 PM
$IBRX https://ucd2e947fcc7b6c887377dc328c2.dl.dropboxusercontent.com/cd/0/inline2/DIDn2C348GykejskLmYFG1SQPttjPVFsN7uwjP0anKt4TNxpdfnFHprUOEXaJsmu9HAJ3mgdyTHDPVsC7EFyhgkyGMSijZt4BYmY883BzervdUd4eQABZ9bWSe7pVTwE-Vr5Yqsr8v-wdaSWGK5CrmWDowY3VV1XxXm3Veq5u_1ocTDklfF3HhzlX3tgxGroy0OdBYtPIbJ-_rXV3XboLMn2MP8oRnxpLRNk5gHA41uSCRNP9ypLCFBGvfJI2J1l3i4YALgAT1ASqYjjw5Bgg54TFxy6PZWpwfgGvE9xw4nhwRwa9cvOeMvZRxD2J11rvaBca_Llb1TH2o4x14kRaMuLNma0KzDccK42EjAS9CGNCMWWsZVAOjXyPtYNmY0Qins/file#
0 · Reply
AlluvialFan
AlluvialFan Sep. 12 at 7:50 PM
$IBRX Was wondering if anyone had bumped into to this company HCWB. Looks like they are investigating an IL-15 fusion with a checkpoint inhibiter (I think I got that right). Very early stage for sure.
1 · Reply
Floridaorange
Floridaorange Sep. 12 at 7:49 PM
$IBRX and yes @Biofrog we won’t forget sepsis!
0 · Reply
Gary9912
Gary9912 Sep. 12 at 6:26 PM
$IBRX Wow this is a big conference. Here’s a link if anyone’s interested. Hopefully we hear something good. https://wclc.iaslc.org/ file:///var/mobile/Library/SMS/Attachments/32/02/33C930CD-30A9-40CD-9D78-3D46D89C76B2/WCLC2026%20-%20Program%20Book_Digital.pdf
1 · Reply
Latest News on IBRX
ImmunityBio put volume heavy and directionally bearish

2026-09-09T16:15:09.000Z - 3 days ago

ImmunityBio put volume heavy and directionally bearish


ImmunityBio appoints Kim as Vice Chairman

2026-08-10T13:10:26.000Z - 4 weeks ago

ImmunityBio appoints Kim as Vice Chairman


ImmunityBio reports Q2 EPS (22c) vs. (10c) last year

2026-08-04T11:45:42.000Z - 5 weeks ago

ImmunityBio reports Q2 EPS (22c) vs. (10c) last year


ImmunityBio Earnings release: Q2 2026

Aug 4, 2026, 7:30 AM EDT - 5 weeks ago

ImmunityBio Earnings release: Q2 2026


ImmunityBio Quarterly report: Q2 2026

Aug 4, 2026, 7:30 AM EDT - 5 weeks ago

ImmunityBio Quarterly report: Q2 2026


ImmunityBio Transcript: AGM 2026

Jun 9, 2026, 1:30 PM EDT - 3 months ago

ImmunityBio Transcript: AGM 2026


ImmunityBio announces results from ITC analyses of NAI with BCG

2026-05-19T11:42:41.000Z - 3 months ago

ImmunityBio announces results from ITC analyses of NAI with BCG


ImmunityBio price target lowered to $12 from $13 at BTIG

2026-05-08T12:57:59.000Z - 4 months ago

ImmunityBio price target lowered to $12 from $13 at BTIG


ImmunityBio reports Q1 EPS (62c) vs (15c) last year

2026-05-07T14:33:22.000Z - 4 months ago

ImmunityBio reports Q1 EPS (62c) vs (15c) last year


ImmunityBio Earnings release: Q1 2026

May 7, 2026, 7:30 AM EDT - 4 months ago

ImmunityBio Earnings release: Q1 2026


ImmunityBio Quarterly report: Q1 2026

May 7, 2026, 7:30 AM EDT - 4 months ago

ImmunityBio Quarterly report: Q1 2026


ImmunityBio presents new comparison results on Anktiva, TAR-200

2026-05-05T11:51:28.000Z - 4 months ago

ImmunityBio presents new comparison results on Anktiva, TAR-200


ImmunityBio Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

ImmunityBio Proxy statement: Proxy filing


ImmunityBio Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

ImmunityBio Proxy statement: Proxy filing


ImmunityBio announces availability of ANKTIVA in Saudi Arabia

2026-04-21T11:56:04.000Z - 4 months ago

ImmunityBio announces availability of ANKTIVA in Saudi Arabia


ImmunityBio reports preliminary Q1 net product revenue $44.2M

2026-04-09T12:01:21.000Z - 5 months ago

ImmunityBio reports preliminary Q1 net product revenue $44.2M


BixbyKnolls
BixbyKnolls Sep. 12 at 10:34 PM
$IBRX whats thr next step? https://lymphocytecount.org/
0 · Reply
todn
todn Sep. 12 at 10:31 PM
$IBRX — this is what a squeeze building sooner rather than later looks like. Bears threw everything at it, including the kitchen sink: ~72% short volume on Thursday. Next session the stock ripped back with a vengeance on much higher volume and closed green. That’s not strength for the shorts. That’s absorption. They emptied the clip and still couldn’t keep it red. This is how the setup looks before it goes
0 · Reply
itco803
itco803 Sep. 12 at 10:23 PM
$IBRX https://x.com/DrPatrick/status/2098771147211038843
0 · Reply
MrMulally
MrMulally Sep. 12 at 10:09 PM
$IBRX Not sure this has been posted here but this poster on X has over 155k followers, has made a few great calls in the past like AMD and PLTR etc…. He is a big fan of our good Dr. Pat . FWIW
0 · Reply
Outcomes
Outcomes Sep. 12 at 10:04 PM
$IBRX ….fight! 🦾 https://x.com/drpatrick/status/2098892737848430711?s=46
0 · Reply
mnholdem
mnholdem Sep. 12 at 8:19 PM
$IBRX “CAR-T cell therapy is a powerful cancer treatment, but its effectiveness and broad use are limited by severe side effects, difficulties treating solid tumors, and high costs.” Severe ToxicitiesCytokine Release Syndrome (CRS): A dangerous, systemic inflammatory response causing high fevers and dangerously low blood pressure.Neurotoxicity (ICANS): Immune effector cell-associated neurotoxicity syndrome causes confusion, seizures, and other cognitive difficulties. Many biotechs have a piece of the puzzle. Dr. Soon-Shiong‘s platforms have a much more wholistic approach with an excellent safety profiles.
0 · Reply
mnholdem
mnholdem Sep. 12 at 8:10 PM
$IBRX https://ucd2e947fcc7b6c887377dc328c2.dl.dropboxusercontent.com/cd/0/inline2/DIDn2C348GykejskLmYFG1SQPttjPVFsN7uwjP0anKt4TNxpdfnFHprUOEXaJsmu9HAJ3mgdyTHDPVsC7EFyhgkyGMSijZt4BYmY883BzervdUd4eQABZ9bWSe7pVTwE-Vr5Yqsr8v-wdaSWGK5CrmWDowY3VV1XxXm3Veq5u_1ocTDklfF3HhzlX3tgxGroy0OdBYtPIbJ-_rXV3XboLMn2MP8oRnxpLRNk5gHA41uSCRNP9ypLCFBGvfJI2J1l3i4YALgAT1ASqYjjw5Bgg54TFxy6PZWpwfgGvE9xw4nhwRwa9cvOeMvZRxD2J11rvaBca_Llb1TH2o4x14kRaMuLNma0KzDccK42EjAS9CGNCMWWsZVAOjXyPtYNmY0Qins/file#
0 · Reply
AlluvialFan
AlluvialFan Sep. 12 at 7:50 PM
$IBRX Was wondering if anyone had bumped into to this company HCWB. Looks like they are investigating an IL-15 fusion with a checkpoint inhibiter (I think I got that right). Very early stage for sure.
1 · Reply
Floridaorange
Floridaorange Sep. 12 at 7:49 PM
$IBRX and yes @Biofrog we won’t forget sepsis!
0 · Reply
Gary9912
Gary9912 Sep. 12 at 6:26 PM
$IBRX Wow this is a big conference. Here’s a link if anyone’s interested. Hopefully we hear something good. https://wclc.iaslc.org/ file:///var/mobile/Library/SMS/Attachments/32/02/33C930CD-30A9-40CD-9D78-3D46D89C76B2/WCLC2026%20-%20Program%20Book_Digital.pdf
1 · Reply
Gary9912
Gary9912 Sep. 12 at 6:23 PM
$IBRX Big lung cancer conference this weekend, they’re definitely there, they have a booth.
0 · Reply
Gary9912
Gary9912 Sep. 12 at 6:03 PM
$IBRX Can’t seem to find specifics from this weekends lung cancer conference, I’ll keep looking …
1 · Reply
Outcomes
Outcomes Sep. 12 at 5:14 PM
$IBRX $PFE $MRNA $MRK mRNA BAD PSS KNOWS. On 29th July 2021 a 61 y.o. New Zealand man took his 1st dose of Pfizer mRNA covid injectable. 3 days later he experienced: *depressed level of consciousness *decreased appetite *abnormal behaviour *migraine Then began 19 days of painful decline, with eventual DEATH 21 days after injection. He was described as having died of sepsis This report was filed with NZ Medsafe, by the patient's brother in law, where he had stayed from the 1st August to 19th. The reporter had accompanied him to see the GP several times during this period. On 19Aug2021 he collapsed and on admission to hospital was diagnosed as having both suffered a STROKE and suffering from a blood infection. HE DIED 🙏🏻 This was a report filed with NZ Medsafe and on-reported to USA VAERS VAERS ID No: 1907934 Video: Senator Ron Johnson @SenRonJohnsonUS Senate Hearing into Covid vaccine injury and death Join ➡️ @ShankaraChetty
0 · Reply
BosqueBandit
BosqueBandit Sep. 12 at 5:10 PM
$IBRX “ Crickets” so far..IBRX is also supposed to be at the H.C. Wainwright Global Investment Conference in New York which starts Monday 14th.. Guess we’ll see if/ what they decide to share about both appearances when / if they feel it’s warranted. Obviously a busy time for IBRX, but I’d certainly like for them to inform investors of any progress they’re making in a timely fashion.
0 · Reply
Outcomes
Outcomes Sep. 12 at 5:02 PM
$IBRX ….’glios’ 🙏🏻 https://x.com/vaccine81097956/status/2098583318048776458?s=46
0 · Reply
MichelleTA
MichelleTA Sep. 12 at 4:54 PM
$IBRX Do you have any news about “ImmunityBio’s events calendar lists “World Lung IASLC (WCLC)” for September 12, 2026. The company has an active lung cancer program centered on ANKTIVA (nogapendekin alfa inbakicept)” Thanks
1 · Reply
arnolddiver
arnolddiver Sep. 12 at 4:45 PM
$IBRX the US is already behind China in Car-T regarding approvals. Both regulatory agencies approved for some blood cancers but China is the first to approve for a solid tumor. In this case, stomach June 2026. So our corrupt FDA and big pharma politics is our country’s worst enemy. Dr Pat trying to change that. We will need some powerful domestic allies.
1 · Reply
albiegf13
albiegf13 Sep. 12 at 4:43 PM
1 · Reply
Bc3345
Bc3345 Sep. 12 at 4:29 PM
$IBRX within the last few years the naval facility in Bahrain was updated and raised to protect from the ocean water level raise from global warming. The acting naval sec said the facility has been to bits. Prepared for the wrong risk. Similarly the friday expectation that the pps rise would hold fell apart in the last 30 minutes. All the early sellers will sell to naked shorts as this goes down another buck. Unless they are prepared. $7.50 - $8.50 has been holding up for a few weeks. That is real news.
0 · Reply
InsightInvestsub
InsightInvestsub Sep. 12 at 4:10 PM
🤔 $IBRX Just waiting on the breakout to happen.
2 · Reply
Eureka2005
Eureka2005 Sep. 12 at 3:54 PM
$IBRX Good morning fellow investors from the great state of Florida, in the two pictures attached you can draw your own conclusions and see how Dr. Patrick is well focused on the fight against cancer. Buy and hold! Stay focused and tuned!
1 · Reply
Outcomes
Outcomes Sep. 12 at 3:48 PM
$IBRX .....'he played a crucial part in developing initial mechanisms of COVID-19 and its interplay with cancer, which remain relevant today.' 'Turbo-Cancers' https://www.24-7pressrelease.com/press-release/511969/marquis-whos-who-honors-yan-leyfman-md-for-expertise-in-health-care-research-education-and-development?swe=40+under+40
0 · Reply